Copper Cu 64 PSMA I&T PET Imaging in Men With Suspected Recurrence of Prostate Cancer (Solar-Recur)
A Phase 3, Multi-Center, Open-label Study to Test the Diagnostic Performance of Copper Cu 64 PSMA I&T PET/CT in Men With Biochemical Recurrence of Prostate Cancer
Sponsor: Curium US LLC
A PHASE3 clinical study on Biochemical Recurrence of Malignant Neoplasm of Prostate and Prostate Adenocarcinoma, this trial is completed. The trial is conducted by Curium US LLC and has accumulated 11 data snapshots since 2024. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
11 versions recorded-
Feb 2026 — Present [monthly]
Completed PHASE3
-
Sep 2025 — Feb 2026 [monthly]
Completed PHASE3
Status: Active Not Recruiting → Completed
-
Jul 2025 — Sep 2025 [monthly]
Active Not Recruiting PHASE3
-
Mar 2025 — Jul 2025 [monthly]
Active Not Recruiting PHASE3
-
Dec 2024 — Mar 2025 [monthly]
Active Not Recruiting PHASE3
Status: Recruiting → Active Not Recruiting
▶ Show 6 earlier versions
-
Nov 2024 — Dec 2024 [monthly]
Recruiting PHASE3
-
Sep 2024 — Nov 2024 [monthly]
Recruiting PHASE3
-
Aug 2024 — Sep 2024 [monthly]
Recruiting PHASE3
-
Jul 2024 — Aug 2024 [monthly]
Recruiting PHASE3
-
May 2024 — Jul 2024 [monthly]
Recruiting PHASE3
Status: Not Yet Recruiting → Recruiting
-
Feb 2024 — May 2024 [monthly]
Not Yet Recruiting PHASE3
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Curium US LLC
For direct contact, visit the study record on ClinicalTrials.gov .